LAZZAROTTO, TIZIANA
 Distribuzione geografica
Continente #
NA - Nord America 8.412
EU - Europa 7.998
AS - Asia 2.012
AF - Africa 348
SA - Sud America 63
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 2
Totale 18.860
Nazione #
US - Stati Uniti d'America 8.372
IT - Italia 2.628
GB - Regno Unito 1.504
SE - Svezia 1.190
DE - Germania 879
CN - Cina 754
VN - Vietnam 554
IN - India 426
UA - Ucraina 408
IE - Irlanda 318
FR - Francia 274
RU - Federazione Russa 201
ZA - Sudafrica 118
EE - Estonia 109
BG - Bulgaria 99
CH - Svizzera 99
TG - Togo 98
JO - Giordania 85
FI - Finlandia 67
AT - Austria 65
NG - Nigeria 56
BE - Belgio 52
SG - Singapore 50
CI - Costa d'Avorio 48
BR - Brasile 35
CA - Canada 33
IR - Iran 30
AU - Australia 23
SC - Seychelles 22
JP - Giappone 21
PL - Polonia 19
GR - Grecia 13
NL - Olanda 13
RO - Romania 13
HR - Croazia 11
HK - Hong Kong 10
LB - Libano 10
TR - Turchia 10
AR - Argentina 9
BD - Bangladesh 8
UZ - Uzbekistan 8
CZ - Repubblica Ceca 7
ES - Italia 7
PT - Portogallo 7
SA - Arabia Saudita 7
CO - Colombia 6
PK - Pakistan 6
CL - Cile 5
DK - Danimarca 4
GH - Ghana 4
ID - Indonesia 4
KR - Corea 4
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
PR - Porto Rico 4
AF - Afghanistan, Repubblica islamica di 3
IL - Israele 3
MX - Messico 3
SK - Slovacchia (Repubblica Slovacca) 3
CY - Cipro 2
LK - Sri Lanka 2
MD - Moldavia 2
MM - Myanmar 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
TH - Thailandia 2
VE - Venezuela 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CV - Capo Verde 1
EC - Ecuador 1
EU - Europa 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MK - Macedonia 1
NP - Nepal 1
RS - Serbia 1
Totale 18.860
Città #
Southend 1.313
Fairfield 968
Chandler 932
Ashburn 683
Houston 640
Woodbridge 522
Wilmington 460
Seattle 444
Princeton 410
Cambridge 367
Ann Arbor 358
Dublin 314
Dong Ket 300
Bologna 266
Jacksonville 200
Milan 177
Rome 167
Nanjing 137
Padova 137
Westminster 135
Berlin 113
Lomé 98
Sofia 95
Turin 90
Amman 85
San Diego 79
Bern 70
Beijing 68
Jinan 66
Redmond 65
Shenyang 65
Florence 63
New York 63
Bremen 62
Saint Petersburg 60
Helsinki 59
Abeokuta 56
Des Moines 56
Vienna 52
Mülheim 50
Abidjan 48
Changsha 47
Hebei 44
Brussels 41
Boardman 38
Medford 37
Redwood City 37
Jiaxing 32
Nanchang 32
Los Angeles 30
Tianjin 30
Aracaju 27
Naples 26
Norwalk 25
Olalla 25
Verona 25
Zhengzhou 25
Dearborn 24
Hangzhou 24
Frankfurt am Main 23
Paris 23
Bari 21
Mahé 21
Pune 21
Falls Church 20
Chicago 19
Haikou 19
Taizhou 18
Tokyo 17
Faenza 16
Guangzhou 16
London 15
Ningbo 15
Rimini 15
Tappahannock 15
Bühl 14
Catania 14
Taiyuan 14
Ferrara 13
Palermo 13
Reggio Emilia 13
Toronto 13
Udine 13
Brescia 12
Fuzhou 12
Boydton 11
Kunming 11
San Venanzo 11
Andover 10
Dallas 10
Salerno 10
Torino 10
Adelaide 9
Forlì 9
Mountain View 9
Parma 9
Singapore 9
Valdagno 9
Washington 9
Alghero 8
Totale 11.531
Nome #
Outcome delle gravidanze con infezione non primaria da CMV 1.389
La gestione clinica dell’infezione da citomegalovirus in gravidanza 346
Impaired dendritic cell immunophenotype and function in heart transplant patients undergoing active cytomegalovirus infection. 319
Citomegalovirus 199
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 198
Infectious meningitis/encephalitis: evaluation of a rapid and fully automated multiplex PCR in the microbiological diagnostic workup 183
Clinical evaluation of the new Roche platform of serological and molecular cytomegalovirus-specific assays in the diagnosis and prognosis of congenital cytomegalovirus infection 175
Brain damage in fetuses congenitally infected by Cytomegalovirus 172
Altered intracellular ATP production by activated CD4+ T-cells in very preterm infants 172
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 169
Automatic environmental disinfection with hydrogen peroxide and silver ions versus manual environmental disinfection with sodium hypochlorite: A multicentre randomized before-and-after trial. 160
Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles 156
Atypical forms of hand, foot, and mouth disease: A prospective study of 47 Italian children 144
Clinical utility of measuring Epstein-Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. 139
Blood monitoring of granzyme B and perforin expression after intestinal transplantation: considerations on clinical relevance. 138
Valacyclovir for cytomegalovirus infection in pregnancy: additional evidences, additional questions 131
Histological findings in foetuses congenitally infected by cytomegalovirus. 128
Successful management of EBV-PTLD in allogeneic bone marrow transplant recipient by virological-immunological monitoring of EBV infection, prompt diagnosis and early treatment. 127
International consensus guidelines on the management of cytomegalovirus in solid organ transplantation. 125
Cytomegalovirus DNA load in amniotic fluid and neonatal outcome. 124
Congenital Cytomegalovirus Infection: Prognostic Value of Maternal DNAemia at Amniocentesis. 123
Congenital cytomegalovirus infection and small for gestational age infants 123
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 122
Role of cerebral ultrasound and magnetic resonance imaging in newborns with congenital cytomegalovirus infection 121
Early and late virological monitoring of cytomegalovirus, Epstein-Barr virus, and human herpes virus 6 infections in small bowel/multivisceral transplant recipients. 121
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. 120
Ultrasound prediction of symptomatic congenital cytomegalovirus infection 119
Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. 118
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients. 116
Congenital cytomegalovirus infection: patterns of fetal brain damage. 116
Monitoring of CMV-specific cell-mediated immunity in heart transplant recipients: clinical utility of the QuantiFERON®-CMV assay for the management of post-transplant CMV infection 116
Cytomegalovirus and Epstein-Barr Virus DNA Kinetics in Whole Blood and Plasma of Allogeneic Hematopoietic Stem Cell Transplantation Recipients 113
Neonatal and long-term ophthalmological findings in infants with symptomatic and asymptomatic congenital cytomegalovirus infection. 112
Cytomegalovirus gN Genotypes Distribution among Congenitally Infected Newborns and Their Relationship with Symptoms at Birth and Sequelae. 111
Clinical evaluation of the Roche Elecsys® CMV IgG Avidity assay 111
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells. 111
Herpes virus in Alzheimer's disease: relation to progression of the disease 110
Diagnosis and prognosis of congenital CMV infection: A case report and review of the literature 110
Infectious agents after liver transplant: etiology, timeline and patients' cell-mediated immunity responses. 110
Antimicrobial Efficacy of Five Probiotic Strains Against Helicobacter Pylori 110
Brain ischemic injury in COVID-19-infected patients: a series of 10 post-mortem cases 110
Fetal cerebral periventricular halo at midgestation: an ultrasound finding suggestive of fetal cytomegalovirus infection. 109
Outbreak of a new measles B3 variant in the Roma/Sinti population with transmission in the nosocomial setting, Italy, November 2015 to April 2016 109
A collaborative study to establish the 1st WHO International Standard for human cytomegalovirus for nucleic acid amplification technology. 109
Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes. 109
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation 107
Validation of an automated immunoglobulin G-only cytomegalovirus (CMV) antibody screening assay and an assessment of the risk of transfusion transmitted CMV from seronegative blood. 106
Salivary glands and human congenital cytomegalovirus infection: What happens in early fetal life? 106
Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys(®) analyser platform. 106
Antibiotic resistance and therapy outcome in H. pylori eradication failure patients. 105
Prenatal diagnosis of symptomatic congenital cytomegalovirus infection 105
Citomegalovirus 104
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. 104
Diagnosis and monitoring of cytomegalovirus infection by the quantification of viral load in dried blood spots samples 104
Antibiotic resistance and therapy for H. pylori infection in immigrant patients managed in Italy 104
L’INFEZIONE CONGENITA DA CYTOMEGALOVIRUS NELLA GRAVIDANZA GEMELLARE 103
Severe acquired cytomegalovirus infection in a full-term, formula-fed infant: case report. 102
Very low birth weight infants born to cytomegalovirus-seropositive mothers fed with their mother's milk: a prospective study. 102
Molecular detection and genetic characterization of circulating measles virus in northern Italy. 102
Pathological post-mortem findings in lungs infected with SARS-CoV-2 102
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 102
SARS-CoV-2/COVID-19 testing: The tower of babel 101
Cytomegalovirus in pregnancy and the neonate 100
Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection. 100
Outcome della gravidanza dopo riscontro precoce di vaginosi batterica. 98
Diagnosi istologica di danno d’organo in feti con infezione da citomegalovirus umano 98
Risposta immune nei feti con infezione da citomegalovirus umano e correlazione con il danno d’organo. 98
Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns 98
Urinary metabolomics in newborns infected by human cytomegalovirus: a preliminary investigation. 98
Ganciclovir-Resistant Cytomegalovirus Infection in a Kidney Transplant Recipient Successfully Treated with Foscarnet and Everolimus. 98
Spotlight on measles in Italy: Why outbreaks of a vaccine-preventable infection continue in the 21st century 97
Monitoring for human cytomegalovirus infection in solid organ transplant recipients through antigenemia and glycoprotein N (gN) variants: evidence of correlation and potential prognostic value of gN genotypes. 97
Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy 96
IMPATTO DELLE INDAGINI DIAGNOSTICHE DI APPROFONDIMENTO E DEL COUNSELLING SULLA PERCENTUALE DI INTERRUZIONI VOLONTARIE DI GRAVIDANZA NELLE DONNE CON RISCONTRO DI IMMUNOGLOBULINE M ANTI-CITOMEGALOVIRUS AL TEST DI SCREENING 95
Different clinical manifestations of HCMV infection in preterm twins: methodological approach. 95
Immunosuppression Modifications Based on an Immune Response Assay: Results of a Randomized, Controlled Trial. 95
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection. 95
Persistent intestinal bleeding due to severe CMV-related thrombocytopenia in a preterm newborn 95
Prophylaxis versus preemptive anti-cytomegalovirus approach for prevention of allograft vasculopathy in heart transplant recipients 94
Results of intestinal and multivisceral transplantation in adult patients: Italian experience. 94
Children and SARS-CoV-2 infection: innocent bystanders…until proven otherwise 93
Recent Advances in the Evaluation of Serological Assays for the Diagnosis of SARS-CoV-2 Infection and COVID-19 92
HHV-6A in syncytial giant-cell hepatitis 91
Steroids in intestinal transplantation 91
Epidemiology of neonatal infections 91
Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes 91
Congenital Human Cytomegalovirus Infection: Identification Of New Prognostic Markers Of Brain Damage In Infected Fetuses 91
Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment 90
Comparison between MALDI-TOF MS and FilmArray Blood Culture Identification panel for rapid identification of yeast from positive blood culture 90
Measles in Italy: Co-circulation of B3 variants during 2014. 90
Toxoplasmosis in Transplant Recipients, Europe, 2010–2014 90
DIAGNOSI ISTOLOGICA DI INFEZIONE FETALE DA CITOMEGALOVIRUS UMANO 89
null 88
Multicenter comparative study of Epstein-Barr virus DNA quantification for virological monitoring in transplanted patients. 88
The "silent" global burden of congenital cytomegalovirus. 86
Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. 86
null 85
Cranial ultrasound scanning and prediction of outcome in newborns with congenital cytomegalovirus infection. 85
Why is cytomegalovirus the most frequent cause of congenital infection? 85
Prognostic significance of blood viral load in newborns with congenital CMV infection. 84
Totale 12.835
Categoria #
all - tutte 49.509
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.509


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019277 0 0 0 0 0 0 0 0 0 0 73 204
2019/20204.219 619 135 100 281 407 410 491 523 523 280 218 232
2020/20212.933 450 170 88 140 98 278 109 149 335 186 124 806
2021/20223.967 258 153 237 506 348 195 106 318 176 278 814 578
2022/20234.725 420 541 251 561 378 356 195 317 769 255 377 305
2023/20242.218 150 273 204 186 213 343 241 243 97 237 31 0
Totale 19.476